P9187

OPD

SIGMAFAST^™, peroxidase substrate, chromogenic, tablet

• 동의어(들): OPD Peroxidase Substrate
• UNSPSC 코드: 12352204
• NACRES: NA.83

속성

• Product Name: SIGMAFAST^™ OPD, tablet
• 양식: tablet
• Quality Level: 200
• solubility: water: 0.5 tablet/10 mL, clear, colorless
• 저장 온도: 2-8°C

설명

애플리케이션

SIGMAFAST^™ OPD (o-Phenylenediamine dihydrochloride) tablets have been developed for use as a soluble substrate for the detection of peroxidase activity in enzyme immunoassays (EIA). OPD is the EIA substrate of choice as it exhibits high sensitivity. EIA applications utilizing OPD may be read in timed assays or stopped with dilute acid solutions for delayed readings.
SIGMAFAST OPD has been used in saliva- virus-like particles (VLP) binding assay. It has also been used to develop enzyme linked immunosorbent assay (ELISA) plates for the detection of rituximab in rat serum samples.

특징 및 장점

SIGMAFAST^™ OPD Tablets require no additional buffers or steps to prepare an active substrate solution.

주의사항

This substrate is hygroscopic and light sensitive

재구성

Each tablet set dissolved in 20 mL deionized water yields a ready-to-use buffered solution containing OPD and urea hydrogen peroxide.

One OPD tablet and one urea hydrogen peroxide/buffer tablet, dissolved in 20 ml of water, provides 20 ml of ready-to-use substrate. When the tablet is dissolved in this manner, the final concentrations will be 0.4 mg/ml OPD, 0.4 mg/ml urea hydrogen peroxide, and 0.05 M phosphate-citrate, pH 5.0. Tablets are individually packaged in foil packets.

법적 정보

SIGMAFAST is a trademark of Sigma-Aldrich Co. LLC

안전성 정보

• 픽토그램: GHS08,GHS05,GHS07,GHS09
• 신호어: Danger
• 유해 및 위험 성명서: H302,H317,H318,H335,H341,H351,H411
• 예방조치 성명서: P273 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 2 - Eye Dam. 1 - Muta. 2 - Skin Sens. 1 - STOT SE 3
• 표적 기관: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3